Cerebral Cortex March 2004; 14:281-299
© Oxford University Press 2004
Co-expression and In Vivo Interaction of Serotonin1A and Serotonin2A Receptors in Pyramidal Neurons of Prefrontal Cortex
1 Department of Neurochemistry, Institut d’Investigacions Biomèdiques de Barcelona (CSIC), IDIBAPs, 08036 Barcelona, Spain, 2 Department of Pharmacology, Weill Medical College, Cornell University, New York, USA, \|[ast ]\| The first three authors contributed equally to this study
The prefrontal cortex plays a key role in the control of higher brain functions and is involved in the pathophysiology and treatment of schizophrenia. Here we report that 
60% of the neurons in rat and mouse prefrontal cortex express 5-HT1A and/or 5-HT2A receptor mRNAs, which are highly co-localized (80%). The electrical stimulation of the dorsal and median raphe nuclei elicited 5-HT1A-mediated inhibitions and 5-HT2A-mediated excitations in identified pyramidal neurons recorded extracellularly in rat medial prefrontal cortex (mPFC). Opposite responses in the same pyramidal neuron could be evoked by stimulating the raphe nuclei at different coordinates, suggesting a precise connectivity between 5-HT neuronal subgroups and 5-HT1A and 5-HT2A receptors in pyramidal neurons. Microdialysis experiments showed that the increase in local 5-HT release evoked by the activation of 5-HT2A receptors in mPFC by DOI (5-HT2A/2C receptor agonist) was reversed by co-perfusion of 5-HT1A agonists. This inhibitory effect was antagonized by WAY-100635 and the prior inactivation of 5-HT1A receptors in rats and was absent in mice lacking 5-HT1A receptors. These observations help to clarify the interactions between the mPFC and the raphe nuclei, two key areas in psychiatric illnesses and improve our understanding of the action of atypical antipsychotics, acting through these 5-HT receptors.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Vazquez-Borsetti, R. Cortes, and F. Artigas Pyramidal Neurons in Rat Prefrontal Cortex Projecting to Ventral Tegmental Area and Dorsal Raphe Nucleus Express 5-HT2A Receptors Cereb Cortex, July 1, 2009; 19(7): 1678 - 1686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. William Moreau, M. Amar, N. Le Roux, N. Morel, and P. Fossier Serotoninergic Fine-Tuning of the Excitation-Inhibition Balance in Rat Visual Cortical Networks Cereb Cortex, June 19, 2009; (2009) bhp114v2. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Santana, G. Mengod, and F. Artigas Quantitative Analysis of the Expression of Dopamine D1 and D2 Receptors in Pyramidal and GABAergic Neurons of the Rat Prefrontal Cortex Cereb Cortex, April 1, 2009; 19(4): 849 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Y. Yuen, Q. Jiang, P. Chen, J. Feng, and Z. Yan Activation of 5-HT2A/C Receptors Counteracts 5-HT1A Regulation of N-Methyl-D-aspartate Receptor Channels in Pyramidal Neurons of Prefrontal Cortex J. Biol. Chem., June 20, 2008; 283(25): 17194 - 17204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Weikop, J. Kehr, and J. Scheel-Kruger Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors J Psychopharmacol, November 1, 2007; 21(8): 795 - 804. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Kargieman, N. Santana, G. Mengod, P. Celada, and F. Artigas Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine PNAS, September 11, 2007; 104(37): 14843 - 14848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Carrasco, L. D. Van de Kar, C. Jia, H. Xu, Z. Chen, R. Chadda, F. Garcia, N. A. Muma, and G. Battaglia Single Exposure to a Serotonin 1A Receptor Agonist, (+)8-Hydroxy-2-(di-n-propylamino)-tetralin, Produces a Prolonged Heterologous Desensitization of Serotonin 2A Receptors in Neuroendocrine Neurons in Vivo J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1078 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Reynolds, B. Arranz, L. A. Templeman, S. Fertuzinhos, and L. San Effect of 5-HT1A Receptor Gene Polymorphism on Negative and Depressive Symptom Response to Antipsychotic Treatment of Drug-Naive Psychotic Patients Am J Psychiatry, October 1, 2006; 163(10): 1826 - 1829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Diaz-Mataix, M. C. Scorza, A. Bortolozzi, M. Toth, P. Celada, and F. Artigas Involvement of 5-HT1A Receptors in Prefrontal Cortex in the Modulation of Dopaminergic Activity: Role in Atypical Antipsychotic Action J. Neurosci., November 23, 2005; 25(47): 10831 - 10843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-B. Assie, V. Ravailhe, V. Faucillon, and A. Newman-Tancredi Contrasting Contribution of 5-Hydroxytryptamine 1A Receptor Activation to Neurochemical Profile of Novel Antipsychotics: Frontocortical Dopamine and Hippocampal Serotonin Release in Rat Brain J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 265 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-w. Zhang and D. Arsenault Gain modulation by serotonin in pyramidal neurones of the rat prefrontal cortex J. Physiol., July 15, 2005; 566(2): 379 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Puig, F. Artigas, and P. Celada Modulation of the Activity of Pyramidal Neurons in Rat Prefrontal Cortex by Raphe Stimulation In Vivo: Involvement of Serotonin and GABA Cereb Cortex, January 1, 2005; 15(1): 1 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Puig, N. Santana, P. Celada, G. Mengod, and F. Artigas In Vivo Excitation of GABA Interneurons in the Medial Prefrontal Cortex through 5-HT3 Receptors Cereb Cortex, December 1, 2004; 14(12): 1365 - 1375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Santana, A. Bortolozzi, J. Serrats, G. Mengod, and F. Artigas Expression of Serotonin1A and Serotonin2A Receptors in Pyramidal and GABAergic Neurons of the Rat Prefrontal Cortex Cereb Cortex, October 1, 2004; 14(10): 1100 - 1109. [Abstract] [Full Text] [PDF]
|
|